Novartis India Reports Minimal Tender Response in Open Offer Update
Novartis India Ltd has reported a significant update regarding the tender response in its ongoing Open Offer, which involves the acquisition of up to 64,19,608 equity shares by a consortium of investors.The Open Offer aims at acquiring up to 64,19,608 fully paidup equity shares of Novartis India Limited (the Target Company), representing 26% of its Voting Share Capital. The Acquirers involved in the transaction include WaveRise Investments Limited, ChrysCapital Fund X, and Two Infinity Partners.
As per the latest disclosures detailing submissions received up to June 22, 2026, the number of shares tendered by public shareholders was minimal across both dematerialized and physical forms.
The details regarding the share tendering are as follows:
| Tender Type | Shares Tendered | Percentage of Offer Size |
|---|---|---|
| Dematerialized Form | NIL Equity Shares | NIL% |
| Physical Form | 10 Equity Shares | 0.00% |
The figures above represent the shares tendered by public shareholders in both the Open Offer Escrow Demat Account and through the Registrar to the Open Offer. It is noted that the quantity of equity shares tendered may differ from the number that the Acquirers will ultimately accept during the conclusion of the Open Offer.
NOVARTIND Stock Price Movement
Novartis India Limited shares rallied on Monday, settling at ₹1491.70 after posting a strong gain of 8.00%. The stock recorded a total traded volume of 53,909 shares during the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.